CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma
Clinical trial NCT03150316 · UNKNOWN
Trial details
- NCT number
- NCT03150316
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-10
- Primary completion
- 2020-06-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.